
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990–2017
Limei Zheng, Chunyan Cui, Oumin Shi, et al.
Gynecologic Oncology (2020) Vol. 159, Iss. 1, pp. 239-247
Closed Access | Times Cited: 57
Limei Zheng, Chunyan Cui, Oumin Shi, et al.
Gynecologic Oncology (2020) Vol. 159, Iss. 1, pp. 239-247
Closed Access | Times Cited: 57
Showing 1-25 of 57 citing articles:
Advances in surface plasmon resonance–based biosensor technologies for cancer biomarker detection
Abdelmonaim Azzouz, Lamia Hejji, Ki‐Hyun Kim, et al.
Biosensors and Bioelectronics (2021) Vol. 197, pp. 113767-113767
Closed Access | Times Cited: 121
Abdelmonaim Azzouz, Lamia Hejji, Ki‐Hyun Kim, et al.
Biosensors and Bioelectronics (2021) Vol. 197, pp. 113767-113767
Closed Access | Times Cited: 121
Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study
Ming Yi, Tianye Li, Mengke Niu, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 107
Ming Yi, Tianye Li, Mengke Niu, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 107
The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer
Afrooz Mazidimoradi, Zohre Momenimovahed, Leila Allahqoli, et al.
Health Science Reports (2022) Vol. 5, Iss. 6
Open Access | Times Cited: 41
Afrooz Mazidimoradi, Zohre Momenimovahed, Leila Allahqoli, et al.
Health Science Reports (2022) Vol. 5, Iss. 6
Open Access | Times Cited: 41
The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17
Daniele Chaves‐Moreira, Marilyn A. Mitchell, Cristina Arruza, et al.
Science Signaling (2022) Vol. 15, Iss. 728
Open Access | Times Cited: 38
Daniele Chaves‐Moreira, Marilyn A. Mitchell, Cristina Arruza, et al.
Science Signaling (2022) Vol. 15, Iss. 728
Open Access | Times Cited: 38
The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
Shiwen Zhang, Cheng Chen, Zejian Lin, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Shiwen Zhang, Cheng Chen, Zejian Lin, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
Sho Sato, Michael A. Gillette, Pamela Santiago, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Sho Sato, Michael A. Gillette, Pamela Santiago, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Investigation of the trends and associated factors of ovarian cancer in Indonesia: A systematic analysis of the Global Burden of Disease study 1990–2021
Brahmana Askandar Tjokroprawiro, Khoirunnisa Novitasari, Renata Alya Ulhaq, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313418-e0313418
Open Access
Brahmana Askandar Tjokroprawiro, Khoirunnisa Novitasari, Renata Alya Ulhaq, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313418-e0313418
Open Access
FTO Inhibits Epithelial Ovarian Cancer Progression by Destabilising SNAI1 mRNA through IGF2BP2
Meige Sun, Xiaocui Zhang, Fangfang Bi, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5218-5218
Open Access | Times Cited: 24
Meige Sun, Xiaocui Zhang, Fangfang Bi, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5218-5218
Open Access | Times Cited: 24
Simultaneous detection of two ovarian cancer biomarkers in human serums with biotin-enriched dendritic mesoporous silica nanoparticles-labeled multiplex lateral flow immunoassay
Hao Liu, Jian Cao, Shou‐Nian Ding
Sensors and Actuators B Chemical (2022) Vol. 371, pp. 132597-132597
Closed Access | Times Cited: 22
Hao Liu, Jian Cao, Shou‐Nian Ding
Sensors and Actuators B Chemical (2022) Vol. 371, pp. 132597-132597
Closed Access | Times Cited: 22
Analysis of the global burden of ovarian cancer in adolescents
Mengting Che, Rutie Yin
International Journal of Gynecological Cancer (2025), pp. 101620-101620
Open Access
Mengting Che, Rutie Yin
International Journal of Gynecological Cancer (2025), pp. 101620-101620
Open Access
Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments
Edgar Yebrán Villegas-Vázquez, Francisco Pável Marín-Carrasco, Octavio D. Reyes‐Hernández, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Edgar Yebrán Villegas-Vázquez, Francisco Pável Marín-Carrasco, Octavio D. Reyes‐Hernández, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Disruption of the FOXM1 Regulatory Region Inhibits Tumor Progression in Ovarian Cancer by CRISPR‐Cas9
Yujie Chen, Yingzhuo Xue, Qiuwen Jiang, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Yujie Chen, Yingzhuo Xue, Qiuwen Jiang, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Causal role of ischemic heart disease in ovarian cancer subtypes
Jianhai Chen, Huabin He, Ling Gao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Jianhai Chen, Huabin He, Ling Gao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Small Organic Molecules-based NIR Agents in Cancer Diagnostics: New Frontiers in Imaging and Therapy
Dr Amal Adnan Ashour, Mohammed Fareed Felemban, Dr Faris J. Tayeb, et al.
Dyes and Pigments (2025), pp. 112648-112648
Closed Access
Dr Amal Adnan Ashour, Mohammed Fareed Felemban, Dr Faris J. Tayeb, et al.
Dyes and Pigments (2025), pp. 112648-112648
Closed Access
Screening ovarian cancers with Raman spectroscopy of blood plasma coupled with machine learning data processing
Fengye Chen, Chen Sun, Zengqi Yue, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 265, pp. 120355-120355
Closed Access | Times Cited: 29
Fengye Chen, Chen Sun, Zengqi Yue, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 265, pp. 120355-120355
Closed Access | Times Cited: 29
Disease Burden and Attributable Risk Factors of Ovarian Cancer From 1990 to 2017: Findings From the Global Burden of Disease Study 2017
Zhangjian Zhou, Xuan Wang, Xueting Ren, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 29
Zhangjian Zhou, Xuan Wang, Xueting Ren, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 29
Inorganic‐Based Aggregation‐Induced Luminescent Materials: Recent Advances and Perspectives
Yu Zhang, Yuefeng Huang, Runjie Miao, et al.
Small Structures (2023) Vol. 4, Iss. 12
Open Access | Times Cited: 11
Yu Zhang, Yuefeng Huang, Runjie Miao, et al.
Small Structures (2023) Vol. 4, Iss. 12
Open Access | Times Cited: 11
Hypoxia-induced miR-9 expression promotes ovarian cancer progression via activating PI3K/AKT/mTOR/GSK3β signaling pathway
Wenjing Zhu, Huanhuan Huang, Yifan Feng, et al.
Neoplasma (2023) Vol. 70, Iss. 02, pp. 216-228
Open Access | Times Cited: 9
Wenjing Zhu, Huanhuan Huang, Yifan Feng, et al.
Neoplasma (2023) Vol. 70, Iss. 02, pp. 216-228
Open Access | Times Cited: 9
Intra-Tumoral Nerve-Tracing in a Novel Syngeneic Model of High-Grade Serous Ovarian Carcinoma
Jeffrey L. Barr, Allison Kruse, Anthony Restaino, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3491-3491
Open Access | Times Cited: 22
Jeffrey L. Barr, Allison Kruse, Anthony Restaino, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3491-3491
Open Access | Times Cited: 22
TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells
Huixi Weng, Xiushan Feng, Lan Yu, et al.
Journal of Ovarian Research (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Huixi Weng, Xiushan Feng, Lan Yu, et al.
Journal of Ovarian Research (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Cancer risk and disease burden of dietary acrylamide exposure in China, 2016
Yiling Li, Jialin Liu, Yibaina Wang, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 238, pp. 113551-113551
Open Access | Times Cited: 12
Yiling Li, Jialin Liu, Yibaina Wang, et al.
Ecotoxicology and Environmental Safety (2022) Vol. 238, pp. 113551-113551
Open Access | Times Cited: 12
Temporal Trends of Ovarian Cancer Between 1990 and 2019, in Asian Countries by Geographical Region and SDI, Comparison with Global Data
Zohre Momenimovahed, Afrooz Mazidimoradi, Niloofar Banakar, et al.
Indian Journal of Gynecologic Oncology (2023) Vol. 21, Iss. 2
Closed Access | Times Cited: 7
Zohre Momenimovahed, Afrooz Mazidimoradi, Niloofar Banakar, et al.
Indian Journal of Gynecologic Oncology (2023) Vol. 21, Iss. 2
Closed Access | Times Cited: 7
Temporal trends in incidence and mortality rates of laryngeal cancer at the global, regional and national levels, 1990–2017
Jing‐Yuan Wang, Qiang-Wei Zhang, Kaixue Wen, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e050387-e050387
Open Access | Times Cited: 16
Jing‐Yuan Wang, Qiang-Wei Zhang, Kaixue Wen, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e050387-e050387
Open Access | Times Cited: 16
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6
Yujue Wang, Lingling Li, Xun Zhang, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Yujue Wang, Lingling Li, Xun Zhang, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study
Anne Weng Ekmann‐Gade, Claus Høgdall, Lene Seibæk, et al.
Gynecologic Oncology (2021) Vol. 164, Iss. 1, pp. 120-128
Open Access | Times Cited: 14
Anne Weng Ekmann‐Gade, Claus Høgdall, Lene Seibæk, et al.
Gynecologic Oncology (2021) Vol. 164, Iss. 1, pp. 120-128
Open Access | Times Cited: 14